These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 18442107

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
    Honig H, Antonini A, Martinez-Martin P, Forgacs I, Faye GC, Fox T, Fox K, Mancini F, Canesi M, Odin P, Chaudhuri KR.
    Mov Disord; 2009 Jul 30; 24(10):1468-74. PubMed ID: 19425079
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A double-blind, placebo-controlled study of intranasal apomorphine spray as a rescue agent for off-states in Parkinson's disease.
    Dewey RB, Maraganore DM, Ahlskog JE, Matsumoto JY.
    Mov Disord; 1998 Sep 30; 13(5):782-7. PubMed ID: 9756146
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Computational analysis of open loop handwriting movements in Parkinson's disease: a rapid method to detect dopamimetic effects.
    Eichhorn TE, Gasser T, Mai N, Marquardt C, Arnold G, Schwarz J, Oertel WH.
    Mov Disord; 1996 May 30; 11(3):289-97. PubMed ID: 8723147
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Continued efficacy and safety of subcutaneous apomorphine in patients with advanced Parkinson's disease.
    Pfeiffer RF, Gutmann L, Hull KL, Bottini PB, Sherry JH, APO302 Study Investigators.
    Parkinsonism Relat Disord; 2007 Mar 30; 13(2):93-100. PubMed ID: 17055329
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial.
    Katzenschlager R, Poewe W, Rascol O, Trenkwalder C, Deuschl G, Chaudhuri KR, Henriksen T, van Laar T, Spivey K, Vel S, Staines H, Lees A.
    Lancet Neurol; 2018 Sep 30; 17(9):749-759. PubMed ID: 30055903
    [Abstract] [Full Text] [Related]

  • 34. [Continuous subcutaneous infusion of apomorphine in Parkinson's disease: retrospective analysis of a series of 81 patients].
    Rambour M, Moreau C, Salleron J, Devos D, Kreisler A, Mutez E, Simonin C, Annic A, Dujardin K, Destée A, Defebvre L.
    Rev Neurol (Paris); 2014 Mar 30; 170(3):205-15. PubMed ID: 24594365
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Treatment of motor fluctuations in Parkinson's disease with subcutaneous injections of apomorphine].
    Merello M, Leiguarda R.
    Medicina (B Aires); 1995 Mar 30; 55(1):5-10. PubMed ID: 7565037
    [Abstract] [Full Text] [Related]

  • 38. Continuous jejunal levodopa infusion in patients with advanced parkinson disease: practical aspects and outcome of motor and non-motor complications.
    Eggert K, Schrader C, Hahn M, Stamelou M, Rüssmann A, Dengler R, Oertel W, Odin P.
    Clin Neuropharmacol; 2008 Mar 30; 31(3):151-66. PubMed ID: 18520982
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Sublingual administration of apomorphine in the treatment of motor fluctuations in Parkinson disease].
    Durif F, Deffond D, Eschalier A, Tournilhac M.
    Rev Neurol (Paris); 1992 Mar 30; 148(10):610-4. PubMed ID: 1295055
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.